DRACP00197 |
Buforin IIb |
RAGLQFPVGRLLRRLLRRLLR |
21 |
Histone H2A |
DRACP00312 |
Lytik |
KLlLKlLkkLLKlLKKK |
17 |
Transferrin receptor (TfR) |
DRACP00313 |
Transferrin receptor (TfR)-lytic hybrid peptide |
THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK |
32 |
Transferrin receptor (TfR) |
DRACP01014 |
B18K |
GFQKVKAQAATCNHTVMA |
18 |
Synthetic |
DRACP01015 |
B18KA |
GFQKVKAQALTCLHTVMA |
18 |
Synthetic |
DRACP01016 |
B18KL |
GFQKVKAQALTCLHTVMA |
18 |
Synthetic |
DRACP01017 |
B18I |
GIGKAIAKAIACIAKAIA |
18 |
Synthetic |
DRACP01018 |
B18L |
GLGKALAKALACLAKALA |
18 |
Synthetic |
DRACP01103 |
INKKI peptide |
INKKI |
5 |
β-Casein |
DRACP01359 |
VEGFR2-Lytic |
ATWLPPRGGGKLlLKlLkkLLKlLKKK |
27 |
Synthetic |
DRACP01366 |
Sema3A(aa371-377) -nLytic |
GRVPYPRGGLLkLLKklLKKLlKL |
24 |
Synthetic |
DRACP01379 |
nLytic |
LLkLLKklLKKLlKL |
15 |
Synthetic |
DRACP01386 |
Sema3A(aa363-377) -nLytic |
NYQWVPYQGRVPYPRGGLLkLLKklLKKLlKL |
32 |
Synthetic |
DRACP01393 |
Tfr-lytic |
THRPPMWSPVWPGGGKLlLKlLkkLLKlLKKK |
32 |
Synthetic |